![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.40 | 2.30 | 2.50 | 2.40 | 2.40 | 2.40 | 203,011 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 9k | -2.04M | -0.0154 | -1.56 | 3.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/5/2024 10:43 | Yes and it is in safety testing so hopefully only a few more short months to wait for someone like AZ - who are spending like water currently - to do a milestone deal..., The best thing being that the inventer now works at AZ so can can speak to the in licensing team over coffee... Couldn't be any better. Full patent too..., | ronpharma | |
23/5/2024 17:05 | RonPharma, It might be of interest that the Co-inventor of Cytolytix CLX001 at Kings College along with Martin Ulmschneider was Charles Chen who was then a PhD Student.Charles Chen is now a Senior Scientist at AstraZeneca.https:// | ![]() lagansider | |
23/5/2024 15:14 | Jason has his issues peepy, like yourself, but he's more likeable.....by quite a stretch... Reflect on that. | ronpharma | |
23/5/2024 15:11 | Preclinical early stage deals hotting up. AZ just done a 500K milestone one for some antibodies,.. They're gearing up to spend big this decade. Bodes well for CLX as it's at same stage. | ronpharma | |
23/5/2024 14:09 | Euda equired CK health plus for $15m. Euda market cap has increased to $2:57 per share. Do you think euda would buyout valirx? 💁a | ![]() david boomtime | |
23/5/2024 08:15 | I just got all of porkys messages from today removed from lse chat. Am I bad 😜🤦 | ![]() david boomtime | |
23/5/2024 06:37 | Porky, maybe re-read the RNS update - no jam tomorrow there, very clear and real. | ![]() wulber | |
23/5/2024 02:42 | Currently pumping the share price with more "Jam tomorrow" stories pre placing again is not going to work. Yes you might fool some of the people and sucker newbies that haven't researched this before but for everyone else, this has been played out so many times now and we have all worn the T-Shirt we are not so stupid. I wait to see the forward plans, the changes have to come. In the meantime, Jam tomorrow wont pay the bloated payroll and benefits costs for lifestyles and so the forward plans need to be compelling if they are to secure Investor support. Its that simple. | ![]() porky9 | |
22/5/2024 23:47 | Porky getting well and truly roasted by his own historical comments. Really enjoying this question is..even after this barrage he still posts! Has to be a real stalker of suzy… that why she has removed Twitter A proper nonce is porky. A pure play 📞 | ![]() david boomtime | |
22/5/2024 22:36 | You're getting spit roasted on lse peppy... I almost can't read your old posts without a sense of nausea coming over me... It's shocking mate. I've never read anything like it even from the most vicious of rampers... I'd die of embarrassment if I'd typed that cringe. Made my evening though, so thanks for posting :-) | ronpharma | |
22/5/2024 14:16 | Forgotten what the upfront payment was now plus the other fees owe?+£2mn?Put to bed any placing if it comes through! | ![]() wulber | |
22/5/2024 14:10 | The euda theorm merger must be close. When this happens then the stench of valirx will be replaced with lavender 3p to 30p over 5 trading days beginning with a rerate of 10p to start. | ![]() david boomtime | |
22/5/2024 13:28 | Happy to wait until 2H2024 as the RNS states. | ![]() wulber | |
22/5/2024 13:06 | Newbies. Listen to chesty and porky. You will save yourself money on this farce of a company. | doerx2 | |
22/5/2024 12:01 | What a dog stock this one truly is!!!! | ![]() chesty1 | |
22/5/2024 11:09 | Well it’s the same game being played and it’s disgusting frankly. This is why the AIM is loosing support due to this kind of situation. Adrian still hasn’t found a replacement CEO and they will need at least a 12 month cash runway if not 24 months ahead of them to join. Manipulation at its best | ![]() porky9 | |
22/5/2024 11:00 | Probably because everyone is sick to death of listening to your “opinion” | goomer1 | |
22/5/2024 10:55 | Rampers Back to removing posts again on LSE. Detailed post on EV removed and also my post on why it’s foolish to rush in until plans are outlined and new bod in situ - crazy I think most of us remember this the last time | ![]() porky9 | |
22/5/2024 09:51 | Well, this is all getting a bit embarrassing now. We were assured yesterday, that it would be rising above 5p, and it would end blue, and it was just profit takers, and the share price would take off again. Looking more like business as usual again today. | ![]() teaboy100 | |
22/5/2024 08:58 | Ungodly hours for an Ungodly Public Company supported by an Ungodly nest of Ungodly traders. | ![]() dope4holders | |
22/5/2024 07:34 | Porkie. You say at the end. Avoid. You are not avoiding valirx as you live on its chat sites. Posting at ungodly hours. What a waste of your precious time if your not invested | ![]() david boomtime | |
22/5/2024 03:06 | LMOL Not to mention incoming placing at 1p if they can secure support, talk about fooling some of the people some of the time. Zero revenue in 15 years other than a £9k three month lab contract, yet 15 raises and three 125:1 share consolidations, should be illegal frankly. IF Adrian can find a CEO and put a business plan together, get cash burn to a more manageable level ie <£1.5m pa, sort out the labs either realistic plan to break even or just get rid and revert to outsourcing, focus on new evaluations, offload the deadwood and change this from a lifestyle business it might then become investable, until then AVOID. | ![]() porky9 | |
21/5/2024 23:02 | We likely to see more rises soon with BOD changes coming soon. | livedata21 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions